Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group None., Horby P., Staplin N., Peto L., Emberson J., Campbell M., Pessoa-Amorim G., Basnyat B., Thwaites L., Van Doorn R., Hamers R., Nel J., Amuasi J., Stewart R., Ghosh D., Hamilton F., Desai P., Easom N., Majumdar J., Hine P., Chadwick D., Cooke G., Sharp S., Esmail H., Baillie K., Buch M., Faust S., Jaki T., Jeffery K., Juszczak E., Knight M., Lim WS., Montgomery A., Mukherjee A., Mumford A., Rowan K., Thwaites G., Mafham M., Haynes R., Landray M.

DOI

10.1101/2024.05.23.24307731

Type

Preprint

Publication Date

2024

Keywords

RECOVERY Collaborative Group

Permalink Original publication